{
  "docId": "019de073-8606-762c-9e2e-06d280bc8199",
  "docSlug": "fe3546a131d6b03dbc05b580d2cda1c4",
  "documentTitle": "CTI BioPharma | Investor Presentation Deck | 24 slides",
  "authorId": "cti-biopharma",
  "authorName": "CTI BioPharma",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 10,
  "pageCount": 24,
  "prevPage": 9,
  "nextPage": 11,
  "slideType": "appendix_methodology",
  "function": "present_framework",
  "density": "balanced",
  "nDataPoints": 5,
  "notes": "The slide uses a process flow diagram to represent clinical trial methodology.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-8606-762c-9e2e-06d280bc8199/10",
  "deckHref": "/decks/019de073-8606-762c-9e2e-06d280bc8199",
  "deckJsonHref": "/decks/019de073-8606-762c-9e2e-06d280bc8199.json",
  "deckAnchorHref": "/decks/019de073-8606-762c-9e2e-06d280bc8199#slide-10",
  "components": [
    {
      "bbox": {
        "h": 0.45,
        "w": 0.78,
        "x": 0.11,
        "y": 0.33
      },
      "kind": "diagram",
      "text": "Study design flow from patient population to randomization to treatment arms and endpoints.",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8aec9586-35db-473d-864c-4429aeaad987",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.8,
        "x": 0.06,
        "y": 0.17
      },
      "kind": "paragraph",
      "text": "PERSIST-2 is the only randomized, active-controlled, Phase 3 study in patients with platelet counts ≤100 x 10⁹/L",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "65a5deaa-130f-4954-9e57-20939db05a12",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.5,
        "x": 0.06,
        "y": 0.88
      },
      "kind": "source-note",
      "text": "1. Mascarenhas J, et al. JAMA Oncol. 2018;4(5):652-659. SVR, spleen volume reduction; TSS, total symptom score.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bceccafa-776f-44dd-9d0f-2b7a27418fe2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.06,
        "y": 0.04
      },
      "kind": "title",
      "text": "PERSIST-2: The Quintessential Study of Cytopenic MF",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c7a9f98d-5e3e-4715-be7f-c99471577aab",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "process",
      "slug": null,
      "matchId": "1bf2ee4b-02f3-4b89-ad6b-86ecb028e626",
      "evidence": "The slide uses a left-to-right flow diagram to describe the clinical trial methodology.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 14,
      "from": 9,
      "beatId": "de10bf08-f5e7-4f0d-920a-819aae17d9f8",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Evidence",
      "beatSlug": "evidence",
      "evidence": "PACIFICA, PERSIST-2, and other clinical trial results",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}